We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Image: EasyM is a highly sensitive blood-based test that traces a biomarker for myeloma called M-protein (photo credit: 123RF)

Blood Test Enables Early Detection of Multiple Myeloma Relapse

A new blood test tracks a myeloma biomarker with higher sensitivity, enabling noninvasive monitoring and earlier relapse detection. More...
28 Apr 2026
Image: New findings underscore limitations of current two-tiered diagnostics in early Lyme Disease infection and point to a need for improved medical education on test interpretation (photo courtesy of Shutterstock)

Study Highlights Low Sensitivity of Current Lyme Tests in Early Infection

New data show two-tiered Lyme serology has low early sensitivity despite high specificity, urging cautious interpretation. More...
28 Apr 2026
Image: Reed-Sternberg cells are a hallmark of Hodgkin lymphoma and are found in affected lymph nodes (photo courtesy of Shutterstock)

New Molecular Insights Support Diagnosis of Hodgkin Lymphoma

New findings identify markers that distinguish Hodgkin lymphoma and reveal immune-evasion features for diagnosis. More...
28 Apr 2026
Image: Researchers identified a set of scalable, blood-based biomarkers associated with PTSD using common clinical laboratory tests (photo courtesy of Adobe Stock)

Routine Blood Tests Identify Biomarkers Linked to PTSD

Researchers identify 16 PTSD-linked biomarkers in common blood tests, enabling systemic monitoring during routine care. More...
28 Apr 2026
Image: Graphical abstract (Jessica L. Corredor et al., The American Journal of Human Genetics (2026). DOI: 10.1016/j.ajhg.2026.03.014)

Risk Prediction Tool Enhances Genetic Testing for Li-Fraumeni Syndrome

A risk model refines TP53 testing decisions and Li-Fraumeni syndrome risk estimates, outperforming guidelines. More...
28 Apr 2026
Image: The MechanoAge platform, shown here on a microscope stage, could be used to detect breast cancer risk. (Photo courtesy of Adam Lau/Berkeley Engineering)

Microfluidic Single-Cell Assay Predicts Breast Cancer Risk

An AI-enabled single-cell microfluidic test quantifies breast cancer risk from cell mechanics, enabling non-genetic assessment More...
27 Apr 2026
Image: New research shows genomic data can identify which precancerous cells progress to myeloid leukemia in children with Down syndrome (photo courtesy of Shutterstock)

Genetic Signature Predicts Myeloid Leukemia Risk in Down Syndrome

Researchers identify transcriptional profiles that predict pre-cancer progression to myeloid leukemia in Down syndrome. More...
27 Apr 2026
New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Immunofluorescence Analyzer
IFA System
New
Benchtop Thermomixer
Biometra TS1 ThermoShaker